halofuginone has been researched along with Urethral Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atala, A; Gorbachinsky, I; Hodges, SJ; Krane, LS; Sirintrapun, J; Yoo, JJ | 1 |
1 other study(ies) available for halofuginone and Urethral Diseases
| Article | Year |
|---|---|
Halofuginone-coated urethral catheters prevent periurethral spongiofibrosis in a rat model of urethral injury.
Topics: Animals; Catheters; Cicatrix; Collagen Type I; Disease Models, Animal; Male; Piperidines; Quinazolinones; Rats; Rats, Sprague-Dawley; Staining and Labeling; Stents; Urethra; Urethral Diseases | 2011 |